Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes | Science Advances
Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis | American Journal of Physiology-Gastrointestinal and Liver Physiology
Mapping oncogenic protein interactions for precision medicine - Sharifi Tabar - 2022 - International Journal of Cancer - Wiley Online Library
Role and Regulation of PDGFRα Signaling in Liver Development and Regeneration - The American Journal of Pathology
Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis | Nature Communications
Cancers | Free Full-Text | Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis | HTML
Cancers | Free Full-Text | Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis | HTML
Cancers | Free Full-Text | Role of Non-Coding RNAs in the Progression of Liver Cancer: Evidence from Experimental Models | HTML
Jacqueline nicola llovet garci Banque de photographies et d'images à haute résolution - Alamy
Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1 ...
![Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/12554/1/fig-3-2x.jpg "Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection [PeerJ]")
Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection [PeerJ]
Veste en jean enfants-filles - Livraison Gratuite | Spartoo !
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes | Science Advances
Jacqueline nicola llovet garci Banque de photographies et d'images à haute résolution - Alamy
Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGIâ•'110
Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3‐mediated cancer development - Seo - Hepatology Communications - Wiley Online Library
Targeting STAT3 in hepatocellular carcinoma: Sorafenib again… - Journal of Hepatology
![Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/12554/1/fig-2-full.png "Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection [PeerJ]")
Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection [PeerJ]
Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment
